Episode

Peptides Are Everywhere. Businesses Are Cashing In.

Podcast
The Journal.
Published
Jul 30, 2026
Duration seconds
1234
Processing state
not_requested
Canonical source
https://pdst.fm/e/traffic.megaphone.fm/WSJ6192530670.mp3
Audio
https://pdst.fm/e/traffic.megaphone.fm/WSJ6192530670.mp3
JSON
/v1/public/podcasts/the-journal-547598/episodes/peptides-are-everywhere-businesses-are-cashing-in
Markdown
/podcast/the-journal-547598/peptides-are-everywhere-businesses-are-cashing-in.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-journal-547598/episodes/peptides-are-everywhere-businesses-are-cashing-in/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-journal-547598/peptides-are-everywhere-businesses-are-cashing-in.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Tickets for our live show in New York are on sale now! Get yours here. Peptides are a huge part of the wellness craze that’s sweeping social media. Demand for restricted peptides has fueled an online gray market for injections promising youth, beauty and strength. Businesses are racing—and taking risks—to get in on the craze. WSJ's Sara Ashley O’Brien explores the burgeoning peptide market and how a recent FDA hearing could signal things are only just getting started. Jessica Mendoza hosts. Further Listening: - Trillion Dollar Shot - The FDA Boss on the Agency's MAHA Makeover Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices